Clinical updates, including trial initiations, enrollment status and data readouts and publications: AI Medical Technology.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dia Imaging Analysis, Northeast Scientific, Vero Biotech.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arima, Avania, Carestream, Cytek, Imperative Care, Kandu Health, Nec, Maxis, Newtopia, Medtronic Canada, Pierian, Rhythm Management Group.

New hires and promotions in the med-tech industry, including: Biosig, Corentec, Cranius, Elevai Labs, Qosina, Upstream Bio.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abbisko, Alpha, Arcturus, Ascletis, Eisai, Greenlight, Help, Huidagene, Junshi, Mesoblast, Pfizer, Pharmala, Zai Lab.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Carsgen, Cidara, Healion, Qurient, Roche, TB Alliance, Tonix, Wuxi XDC, Ymmunobio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biophytis, Daiichi Sankyo, Ocumension, Oricell, Qurient, Sciwind.

Biopharmas in Asia-Pacific raising money in public or private financings: Cytomed, Resolutionrx, Respirerx, Structure.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accutar, Biogen, Bioxytran, Egret, Endogena, Gilead, Hinova, Inmagene, Neogap, Neurosense, Sage, Sandoz, Takeda.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AAHI, Actinium, Adcanz, Alvotech, Atreca, Atyr, Bioasis, BMY, CKD, Dragonfly, Indivior, Kyorin, Merck & Co., Midatech, Movantik Acquisition, Nabriva, Omeros, Opiant, Rayner, Redhill, Rubedo, Sensei, Xencor.